Improved Analysis of Preservatives in Cosmetics Using a Unique Core-Shell Phase
The Application Notebook
Phenomenex Application Note
Introduction
Preservatives prevent product deterioration and deter any possible health risks microorganisms may cause to the consumer; however, a disadvantage of using such agents is that they may cause adverse effects, such as allergic responses and irritation. There is a need today for a fast, efficient and selective HPLC method to screen for such common and dangerous preservatives.
Results
Cosmetic products can only use a limited number of preservatives selected from a positive list, Annex VI of the Cosmetics Directive, which also defines preservative maximum permitted levels and areas of use. The esters of parahydroxybenzoic acid (paraben), methyl paraben, ethyl paraben, propyl paraben and butyl paraben are standard substances among the preservatives list.
Figure 1: High performance separation of 15 preservatives on Kinetex 2.6 µm XB-C18.
Figure 1 illustrates the ability of the Kinetex XB-C18, 2.6 µm core-shell column to rapidly screen and separate all 15 compounds. In this separation, the Kinetex XB-C18 column offered a peak capacity of 445, which was higher than any other column evaluated in the experiment. Peak capacity is the best measure of performance for a gradient separation and high peak capacity values indicate increased analyte resolution over a given analysis time.
The core-shell particle morphology allows for faster mass transfer of analytes into and out of the stationary phase as compared to fully-porous silica particles. In addition, the very narrow particle size distribution inherent in core-shell silica particles, as compared to fully-porous particles, results in less band broadening.
Kinetex 2.6 µm XB-C18 was able to separate the chlorinated compounds triclosan and triclocarban, which can be challenging. This is likely due to the unique XB-C18 selectivity. The Kinetex XB-C18 chemistry contains protective di-isobutyl side chains that shield the silica surface. In addition, the surface is endcapped with trimethylsilane.
Analysis of preservatives in cosmetics was accomplished at an operating pressure under 400 bar and may therefore be used on conventional HPLC systems without the need for specialized ultra-high pressure equipment.
Conclusion
An ultra-high performance liquid chromatography method has been developed for the simultaneous determination of 15 preservatives in cosmetics. The method was developed to achieve the best balance of analysis time and separation.
The Kinetex XB-C18, 2.6 µm column provided high peak capacity and the unique selectivity of the XB-C18 was wellsuited for the application.
Phenomenex Inc.
411 Madrid Ave., Torrance, California 90501, USA
tel: +1 310 212 0555 fax: +1 310 212 7768
Website: www.phenomenex.com
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
